SGLT2 inhibitors in T2D and associated comorbidities - Differentiating within the class

Guntram Schernthaner; Heinz Drexel; Evgeny Moshkovich; Birute Zilaitiene; Emil Martinka; Leszek Czupryniak; Tamás Várkonyi; Andrej Janež; Kristīne Ducena; Katarina Lalić; Tsvetalina Tankova; Martin Prázný; Lea Smirčić Duvnjak; Olga Sukhareva; Harald Sourij

doi:10.1186/s12902-019-0387-y

SGLT2 inhibitors in T2D and associated comorbidities - Differentiating within the class

Guntram Schernthaner^*
, Heinz Drexel
, Evgeny Moshkovich
, Birute Zilaitiene
, Emil Martinka
, Leszek Czupryniak
, Tamás Várkonyi
, Andrej Janež
, Kristīne Ducena
, Katarina Lalić
, Tsvetalina Tankova
, Martin Prázný
, Lea Smirčić Duvnjak
, Olga Sukhareva
, Harald Sourij

^*Corresponding author for this work

University of Latvia

Rudolfstitung Hospital
Academic Teaching Hospital Feldkirch
Drexel University
Private University of the Principality of Liechtenstein
University of Bern
Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT)
Meir Hospital Sapir Medical Center
Lithuanian University of Health Sciences
National Institute of Endocrinology and Diabetology
Medical University of Warsaw
University of Szeged
University of Ljubljana
University of Belgrade
Medical University Sofia
Charles University
University Hospital Merkur
Russian Academy of Medical Sciences
Medical University of Graz

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Original language	English
Journal	BMC Endocrine Disorders
Volume	19
Issue number	1
DOIs	https://doi.org/10.1186/s12902-019-0387-y
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

OECD Field of Science

3. Medical and Health Sciences

Access to Document

10.1186/s12902-019-0387-y

Cite this

Schernthaner, G., Drexel, H., Moshkovich, E., Zilaitiene, B., Martinka, E., Czupryniak, L., Várkonyi, T., Janež, A., Ducena, K., Lalić, K., Tankova, T., Prázný, M., Smirčić Duvnjak, L., Sukhareva, O., & Sourij, H. (2019). SGLT2 inhibitors in T2D and associated comorbidities - Differentiating within the class. BMC Endocrine Disorders, 19(1). https://doi.org/10.1186/s12902-019-0387-y

@article{b279ed2e381e4d6dbe346db1946aba54,

title = "SGLT2 inhibitors in T2D and associated comorbidities - Differentiating within the class",

author = "Guntram Schernthaner and Heinz Drexel and Evgeny Moshkovich and Birute Zilaitiene and Emil Martinka and Leszek Czupryniak and Tam{\'a}s V{\'a}rkonyi and Andrej Jane{\v z} and Kristīne Ducena and Katarina Lali{\'c} and Tsvetalina Tankova and Martin Pr{\'a}zn{\'y} and \{Smir{\v c}i{\'c} Duvnjak\}, Lea and Olga Sukhareva and Harald Sourij",

year = "2019",

doi = "10.1186/s12902-019-0387-y",

language = "English",

volume = "19",

journal = "BMC Endocrine Disorders",

issn = "1472-6823",

publisher = "BioMed Central Ltd",

number = "1",

}

Schernthaner, G, Drexel, H, Moshkovich, E, Zilaitiene, B, Martinka, E, Czupryniak, L, Várkonyi, T, Janež, A, Ducena, K, Lalić, K, Tankova, T, Prázný, M, Smirčić Duvnjak, L, Sukhareva, O & Sourij, H 2019, 'SGLT2 inhibitors in T2D and associated comorbidities - Differentiating within the class', BMC Endocrine Disorders, vol. 19, no. 1. https://doi.org/10.1186/s12902-019-0387-y

TY - JOUR

T1 - SGLT2 inhibitors in T2D and associated comorbidities - Differentiating within the class

AU - Schernthaner, Guntram

AU - Drexel, Heinz

AU - Moshkovich, Evgeny

AU - Zilaitiene, Birute

AU - Martinka, Emil

AU - Czupryniak, Leszek

AU - Várkonyi, Tamás

AU - Janež, Andrej

AU - Ducena, Kristīne

AU - Lalić, Katarina

AU - Tankova, Tsvetalina

AU - Prázný, Martin

AU - Smirčić Duvnjak, Lea

AU - Sukhareva, Olga

AU - Sourij, Harald

PY - 2019

Y1 - 2019

UR - https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-019-0387-y

U2 - 10.1186/s12902-019-0387-y

DO - 10.1186/s12902-019-0387-y

M3 - Article

C2 - 31208401

SN - 1472-6823

VL - 19

JO - BMC Endocrine Disorders

JF - BMC Endocrine Disorders

IS - 1

ER -

SGLT2 inhibitors in T2D and associated comorbidities - Differentiating within the class

UN SDGs

OECD Field of Science

Access to Document

Other files and links

Cite this